Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10.

Ghadjar, Pirus; Hayoz, Stefanie; Bernhard, Jürg; Zwahlen, Daniel R; Stein, Jürgen; Hölscher, Tobias; Gut, Philipp; Polat, Bülent; Hildebrandt, Guido; Müller, Arndt-Christian; Putora, Paul Martin; Papachristofilou, Alexandros; Schär, Corinne; Dal Pra, Alan; Biaggi Rudolf, Christine; Wust, Peter; Aebersold, Daniel; Thalmann, George (2018). Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10. Radiotherapy and oncology, 126(2), pp. 257-262. Elsevier 10.1016/j.radonc.2017.10.025

[img] Text
Thalmann_RadiotherOncol_Impact of dose.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (420kB) | Request a copy

INTRODUCTION

Adjuvant radiation therapy (aRT) after radical prostatectomy (RP) is associated with impaired urinary continence recovery as compared to surveillance. Less is known regarding the effect of salvage radiation therapy (sRT) dose intensification on continence outcomes.

MATERIALS AND METHODS

Urinary continence recovery was investigated within a multicentre randomized trial in biochemically recurrent prostate cancer patients who received either 64 Gy (32 fractions) or 70 Gy (35 fractions) sRT. Incontinence was assessed using Common Toxicity Criteria for Adverse Events v4.0 at baseline, at the end of sRT and 3 months afterward. Quality of life (QoL) was assessed with the EORTC QoL questionnaires C30 and PR25 at baseline and 3 months after completion of sRT. A total of 344 patients were evaluable.

RESULTS

At baseline 233 (68%) of patients were fully continent and 14% in both arms became incontinent three months after treatment. Of the remaining 111 (32%) patients being incontinent at baseline, continence recovery was achieved 3 months after sRT by 44% vs. 41% with 64 vs. 70 Gy, respectively (p = 0.8). This analysis is limited by its short follow-up.

CONCLUSIONS

Dose intensification of sRT had no impact on early urinary continence recovery or prevalence of de novo incontinence.

Item Type:

 Journal Article (Original Article)

Division/Institute:

 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

 Ghadjar, Pirus, Bernhard, Jürg Theodor, Putora, Paul Martin, Dal Pra, Alan, Aebersold, Daniel Matthias, Thalmann, George

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 0167-8140

Publisher:

 Elsevier

Language:

 English

Submitter:

 Laetitia Hayoz

Date Deposited:

 30 Jan 2018 14:23

Last Modified:

 02 Mar 2023 23:30

Publisher DOI:

 10.1016/j.radonc.2017.10.025

PubMed ID:

 29103826

Uncontrolled Keywords:

 Prostate cancer Radiation therapy Salvage Urinary continence

BORIS DOI:

 10.7892/boris.108752

URI:

 https://boris.unibe.ch/id/eprint/108752

Actions (login required)

Edit item Edit item
Provide Feedback